Poster: AACR (American Association for Cancer Research), April 5-10, 2024, San Diego CA

A systemically delivered, clinically-ready, attenuated Salmonella Typhimurium strain ACTM-838 alters the tumor microenvironment and provides durable anti-tumor activity in vivo VIEW POSTER PDF